Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Analysis of Revenues

Microsoft Excel

Revenues as Reported

Bristol-Myers Squibb Co., income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net product sales 43,778 44,671 45,055 41,321 25,174
Alliance revenues 608 742 716 615 597
Other revenues 620 746 614 582 374
Revenues 45,006 46,159 46,385 42,518 26,145

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Item Description The company
Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Bristol-Myers Squibb Co. revenues decreased from 2021 to 2022 and from 2022 to 2023.